In one embodiment of the invention, a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt, solvate, clathrate, and prodrug thereof, or a pharmaceutical composition comprising a compound of formula I or a pharmaceutically acceptable salt, solvate, clathrate, and prodrug thereof, is administered to a patient in need of treatment of cancer [url=https://lasix.beauty]lasix and hyponatremia[/url] eCollection 2018 Oct Dec